2014
DOI: 10.1007/174_2013_902
|View full text |Cite
|
Sign up to set email alerts
|

Contrast Medium-Induced Nephropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0
4

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 209 publications
1
5
0
4
Order By: Relevance
“…The result of this study showed that there was no significant difference (p > 0.05) in the concentration of creatinine in the serum of diabetic groups compared to non-diabetic and dietary diabetic control groups (Table 2). This is in agreement with the findings of Stefan et al (2004) and Thomsen et al (2014), that creatinine is not a reliable biomarker in determining early damage to the kidney as it does not give an optimum expression of renal function [18,19]. However, the levels of urea increased significantly (p < 0.05) in the diabetic groups using metformin; metformin and glimepiride; metformin and glibenclamide.…”
Section: Discussionsupporting
confidence: 91%
“…The result of this study showed that there was no significant difference (p > 0.05) in the concentration of creatinine in the serum of diabetic groups compared to non-diabetic and dietary diabetic control groups (Table 2). This is in agreement with the findings of Stefan et al (2004) and Thomsen et al (2014), that creatinine is not a reliable biomarker in determining early damage to the kidney as it does not give an optimum expression of renal function [18,19]. However, the levels of urea increased significantly (p < 0.05) in the diabetic groups using metformin; metformin and glimepiride; metformin and glibenclamide.…”
Section: Discussionsupporting
confidence: 91%
“…Apart from serious allergoid or anaphylactoid reactions, which can occur after administration of only small amounts of any CM, 76 the most relevant side effect of iodinated CM which possibly has a correlation with dose is contrast-induced nephropathy, 77 more recently referred to as contrast-induced acute kidney injury. Although the existence of contrast-induced nephropathy/contrast-induced acute kidney injury in contrast-enhanced CT is currently a matter of debate, 78 84 patients with renal impairment or an elevated risk of renal impairment are nevertheless still likely to benefit most from a reduction of contrast dose.…”
Section: Safety and Tolerability Aspects Of Iodinated Contrast Adminimentioning
confidence: 99%
“…Although the existence of contrast-induced nephropathy/contrast-induced acute kidney injury in contrast-enhanced CT is currently a matter of debate, 78 84 patients with renal impairment or an elevated risk of renal impairment are nevertheless still likely to benefit most from a reduction of contrast dose. 77 …”
Section: Safety and Tolerability Aspects Of Iodinated Contrast Adminimentioning
confidence: 99%
“…Therefore, the prevalence in this group of patients, particularly those with a glomerular filtration rate below 20 mL/ min 1.73m 2 , is not based on evidence but best estimates. It is probably somewhere in the range of 10-15% (12). This figure is important when one compares gadolinium-and iodine-based contrast media as the risk of CIN after iodine-based contrast media must be compared to the risk of nephrogenic systemic fibrosis (see below), as the opposite is not clinically relevant (iodine-based contrast media do not cause nephrogenic systemic fibrosis, and contrast mediuminduced nephropathy after gadolinium-based contrast media is extremely rare).…”
Section: Contrast-induced Nephropathymentioning
confidence: 99%